AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
IT
•
April 24, 2026
•
1 Views
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Source: https://www.wired.com/feed/rss - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
